Effects of imatinib mesylate on cutaneous neurofibromas associated with neurofibromatosis type 1

Imatinib mesylate seemed to inhibit development of cutaneous neurofibromas (c‐NFs) and promote growth of pre‐existing c‐NFs in our neurofibromatosis type 1 case. This report potentially provides new findings in the effects of imatinib mesylate.

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Clin Case Rep
Asıl Yazarlar: Yasuda, Ken‐ichi, Nobeyama, Yoshimasa, Ishiji, Takaoki, Ota, Arihito, Asahina, Akihiko
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley and Sons Inc. 2020
Konular:
Case Reports
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7669387/
https://ncbi.nlm.nih.gov/pubmed/33235741
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ccr3.3071
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller